VEGFR2 Inhibitor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma (NCT04393506) | Shanghai Jiao Tong University School of Medicine | 2020-04-23 |
Track VEGFR2 Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.